Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology

Synthetic biology promises to make biology easier to engineer (Endy 2005), enabling more people in less formal research settings to participate in modern biology. Leveraging advances in DNA sequencing and synthesis technologies, genetic assembly methods based on standard biological parts (e.g. BioBricks), and increasingly precise gene-editing tools (e.g. CRISPR), synthetic biology is helping increase the reliability of and accessibility to genetic engineering. Although potentially enabling tremendous opportunities for the advancement of the global bioeconomy, opening new avenues for the creation of health, wealth and environmental sustainability, the possibility of a more ‘democratic’ (widely accessible) bioengineering capability could equally yield new opportunities for accidental, unintended or deliberate misuse. Consequently, synthetic biology represents a quintessential ‘dual-use’ biotechnology – a technology with the capacity to enable significant benefits and risks (NRC 2004).

show abstract

Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology

Cited by 11 publications

References 19 publications

Estimating and Predicting Exposure to Products from Emerging Technologies

Estimating and Predicting Exposure to Products from Emerging Technologies

Synthetic biology’s multiple dimensions of benefits and risks: implications for governance and policies

Opportunities, Challenges, and Future Considerations for Top-Down Governance for Biosecurity and Synthetic Biology

Contact Info

Product

Resources

About